3-(3-Chloro-phenyl)-3-oxo-propionic acid ethylester, 95.0%, 1g

Ethyl 3,4-dichloro-2-fluorobenzoate, 97%, 250mg

2-Bromo-5-fluoro-1,3-thiazole, 95.0%, 500mg

Benzyl Acetoacetate>95.0%(GC)(T)500mL

5-Bromo-2-isopropylthiazole, 97%, 1g

4-Fluoro-3-nitrotoluene>98.0%(GC)5g

(4-Hydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone, 95.0%, 25g

3-Formyl-4-methylbenzoic acid, 98+%, 250mg

2,3,4,5,6-PENTABROMOBENZYL ALCOHOL, 97%, 25g

Ethyl 4-methylisoxazole-3-carboxylate, 97%, 1g

Benzyl (1-(hydroxymethyl)cyclopropyl)carbamate, 95.0%, 100g

iScope IS.1158-PLPHi Biocular for phase contrast with Plan phase IOS objectives and Rackless cross stage (infinity - ergonomic tilting head)

2-Bromo-3-fluorophenol, 98.0%, 100g